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ABSTRACT
Background: Complications following laparoscopic cho-
lecystectomy are encountered infrequently due to increas-
ing proficiency in laparoscopic surgery. The occurrence of
portal venous thrombosis following laparoscopic chole-
cystectomy has not been previously described and forms
the basis of this report.
Methods: A healthy, 32-year-old, female on oral contra-
ceptives underwent an uneventful laparoscopic cholecys-
tectomy for symptomatic gallbladder disease. Sequential
compression devices and mini-dose unfractionated hepa-
rin were used before the procedure. The patient was
discharged home on the first postoperative day without
complaints. She returned 1 week later with nausea, bloat-
ing, and diffuse abdominal pain.
Results: Ultrasonography of the abdomen revealed
thrombosis of the portal vein not seen in the preoperative
ultrasound and the superior mesenteric vein. Computer
tomography of the abdomen and pelvis on the same day
confirmed this finding and showed a wedge-shaped in-
farction of the right lobe of the liver. The patient was
anticoagulated with intravenous heparin. An extensive
coagulation workup revealed elevation of the Immuno-
globulin G anticardiolipin antibody. A percutaneous
transhepatic portal vein thrombectomy was performed.
A postprocedure duplex ultrasound of the abdomen dem-
onstrated recannalization of the portal venous system with
no flow voids. Anticoagulation therapy was continued,
and the patient was discharged home with resolution of
her ileus. She was maintained on a therapeutic dose of
warfarin.
Conclusions: This case demonstrates an unusual compli-
cation of laparoscopic cholecystectomy. It may have re-
sulted from the use of oral contraceptives, elevation of the
Immunoglobulin G anticardiolipin antibody, unrecog-
nized trauma, and was accentuated by the pneumoperi-
toneum generated for the performance of the laparo-
scopic cholecystectomy. Our case report provides insight
and poses questions regarding necessary perioperative
measures for thromboprophylaxis in young females on
oral contraceptives undergoing elective laparoscopic ab-
dominal surgery.
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INTRODUCTION
Complications following laparoscopic cholecystectomy
can be due to laparoscopy itself, or the cholecystectomy.
Hemorrhage, bile leak, and injury to a major bile duct are
complications related to removal of the gallbladder. Lapa-
roscopic complications occur secondary to carbon diox-
ide pneumoperitoneum or the instruments inserted
through the abdominal wall. The complications of the
pneumoperitoneum, such as gas embolism, vagal reac-
tion, ventricular arrhythmias, and hypercarbia with acido-
sis, are well known. The occurrence of portal venous
thrombosis following laparoscopic cholecystectomy has
not been previously reported and forms the basis of this
report.
CASE REPORT
A healthy, 32-year-old female presented with a history of
intermittent right upper quadrant pain for a few months.
Physical examination was significant only for some mild
abdominal tenderness over the right upper quadrant. The
laboratory workup was normal. Past medical and surgical
history was unremarkable except for the fact that the
patient was on oral contraceptives. A diagnostic abdomi-
nal ultrasound study was performed that revealed multi-
ple small polyps in the gallbladder, as well as a patent
portal vein system. The patient underwent an uneventful
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CASE REPORTlaparoscopic cholecystectomy. Sequential compression
devices and mini-dose unfractionated heparin were used
for prophylaxis of deep vein thrombosis because the pa-
tient was on oral contraceptives. Pneumoperitoneum was
established by the open technique to a pressure of 15 mm
Hg. The patient was placed in the reverse Trendelenburg
position. Electrocautery was used only to detach the gall-
bladder from the liver bed.
The patient was discharged to home on the first postop-
erative day without complaints and on a regular diet. A
few days later, the patient went to the emergency room
with vague abdominal pain. The ultrasound at that point
was normal, and the patient went home the same day. She
returned 1 week later with complaints of diffuse abdom-
inal pain, bloating, and nausea. Ultrasonography of the
abdomen revealed a rounded area of echogenicity at the
bifurcation of the splenic vein and superior mesenteric
vein that extended along the course of the portal vein and
the superior mesenteric vein. This finding was consistent
with thrombosis of these vessels (Figure 1). Computed
tomography of the abdomen and pelvis with intravenous
and oral contrast confirmed the findings and in addition
demonstrated a wedge-shaped zone of decreased attenu-
ation involving the lateral aspect of the right lobe of the
liver compatible with liver infarction (Figure 2). A mes-
enteric angiogram was performed and confirmed the di-
agnosis. Coagulation studies including prothrombin time,
partial thromboplastin time, platelet count, protein C&S,
antithrombin III, lupus anticoagulant, and platelet aggre-
gation studies were normal. Anticardiolipin antibody Im-
munoglobulin G (IgG) was elevated to 19 g-phospholipid
level (GPL) units (normal range, 0 to 10), with negative
IgM and IgA. The patient was immediately started on
intravenous heparin anticoagulation, with improvement
of her symptoms. A percutaneous transhepatic portal vein
thrombectomy was performed with a postprocedure du-
plex abdominal ultrasound that demonstrated recannal-
ization of the portal venous system with no flow voids.
Anticoagulation was continued, and the patient was dis-
charged home on a regular diet and therapeutic doses of
oral warfarin. The patient has since been asymptomatic
for 2 years.
DISCUSSION
The practice of laparoscopic cholecystectomy has in-
creased rapidly over the last 14 years and has rapidly
become the standard of care for the management of symp-
tomatic gallbladder disease. Safety, efficacy, and patient
benefits have been established. Complications following
laparoscopic cholecystectomy are infrequent and include
major bile duct injury, major vascular injury during trocar
placement, cardiopulmonary failure, wound infections,
and spillage of stones into the peritoneal cavity with
subsequent abscess and or fistula formation. To our
knowledge, the occurrence of isolated portal vein throm-
bosis and superior mesenteric vein thrombosis following
laparoscopic cholecystectomy has not been previously
described and forms the basis of this discussion. Portal
vein thrombosis as a rare complication of laparoscopic
splenectomy in patients with idiopathic thrombocytope-
nia was previously reported. Several factors could have
contributed to portal vein thrombosis. Decreased splanch-
nic flow with insufflation of CO2 has been shown.2,3 Hy-
Figure 1. Postoperative ultrasound demonstrates patent portal
venous system. See arrow.
Figure 2. Computed tomography of the abdomen with intrave-
nous and oral contrast demonstrates thrombus in the portal vein.
See arrow.
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duced mesenteric flow from increased intraperitoneal
pressure secondary to CO2 insufflation.4 Hepatic microcir-
culation, portal venous blood flow, and renal blood flow
are decreased with increased intraabdominal pressure as
documented in experimental as well as in clinical stud-
ies.5–8 Takagi et al7 showed that the diameter of the portal
venous trunk and the mean portal blood flow was signif-
icantly decreased with an elevation of intraperitoneal
pressure (IP) 10 mm Hg. The flow was less than one
tenth of the baseline value when the IP was 16 mm Hg.
Jakimowitcz et al9 demonstrated a stepwise reduction of
portal blood flow from 990 (100 mL/min) to 568 (81
mL/min) at 7 mm Hg of IP, compared with baseline flow
measured at 0mm Hg. In the same study, at an IP level of
14 mm Hg, which was used routinely for all laparoscopic
procedures, the portal venous flow sustained a further
drop to 440 (56 mL/min), corresponding to a 53% reduc-
tion in the portal venous flow compared with the initial
baseline value.9 Junghans et al6 in experimental studies,
reported that the head up position in association with an
elevation of IP greater than 12 mm Hg should be avoided
during laparoscopic surgery because they compromise
hepatic and renal blood flow. Infrarenal inferior vena
caval flow was also been shown in experimental reports
to decrease during insufflation with CO2.10 The above-
mentioned studies confirm the reduction of portal venous
flow and also a relationship between the drop in portal
venous flow and the increase in intraabdominal pressure.
With regard to the above observations, a selective setting
of IP during laparoscopic surgery is advocated with low
pressure or gasless abdominal wall lift approaches.9,11
In our case, other factors may have accentuated the effects
of the pneumoperitoneum. For example, the presence of
a preexisting portal vein thrombosis or trauma occurring
during the procedure, even though we found no evidence
of this. The use of oral contraceptives has been estab-
lished as an independent risk factor for the development
of deep vein thrombosis and approximately one quarter
of idiopathic events among women of childbearing age
have been attributed to oral contraceptives.12 The risk is
increased when oral contraceptive use is combined with
surgery and inherited inhibitor deficiencies.12 An alter-
ation in the coagulation system with an increase in blood
viscosity, fibrinogen, plasma levels of factors VII and X,
and platelet adhesion and aggregation may contribute to
this thrombotic tendency.12 No association with portal
vein thrombosis has been reported. Elevated levels of
cardiolipin antibody (IgG) with normal IgM and IgA also
predisposes to portal vein thrombosis. The significance of
an isolated, mild elevation of IgG in a patient is not clear.13
The presence of antiphospholipid antibodies predisposes
to both arterial and venous thrombosis.14 Portal vein
thrombosis was reported in one patient from a series of
800 in which the level of elevation of IgG, the partial
thromboplastin time, the value of dilute Russell viper
venom (d RVV), as well as the association with IgM was
not very clear.15
The diagnosis of portal vein thrombosis can be accurately
established with an abdominal duplex scan or computed
tomography. If their results are equivocal, then arterial
portography may be performed. Treatment options in
addition to anticoagulation therapy include open por-
tomesenteric venous thrombectomy or percutaneous
transhepatic procedures, including thrombectomy, infu-
sion of fibrinolytic agents, balloon dilation, and stenting.
The optimal duration of anticoagulation is unknown. For
those with primary coagulation disorders, lifelong antico-
agulation is necessary. As most recurrent thromboses oc-
cur within 6 weeks of portomesenteric thrombosis in pa-
tients with treatable secondary causes of the portal venous
thrombosis, removal of the risk factor and a 6-month
course of anticoagulation should be adequate.
CONCLUSION
The perioperative measures for thromboprophylaxis used
in young, otherwise healthy females taking oral contra-
ceptives and undergoing laparoscopic abdominal surgery
needs to be reevaluated. The above case poses more
questions than answers that the medical community needs
to address to avoid such complications in the future.
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